<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01905501</url>
  </required_header>
  <id_info>
    <org_study_id>Versione 02.01.2013</org_study_id>
    <nct_id>NCT01905501</nct_id>
  </id_info>
  <brief_title>Sevoflurane Protective Effect on Ischemia-reperfusion Injury. Multicenter, Randomized Controlled Trial</brief_title>
  <official_title>Sevoflurane Protective Effect on Ischemia-reperfusion Injury in Patients Undergoing Reconstructive Plastic Surgery With Microsurgical Flap. Multicenter, Randomized Controlled Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Regina Elena Cancer Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Regina Elena Cancer Institute</source>
  <brief_summary>
    <textblock>
      This study aimed to evaluate the possible protective effect of anesthetic technique
      balanced(with sevoflurane) compared with total intravenous anesthetic technique
      (propofol,remifentanil). The hypothesis is that the Sevoflurane may exert protective effect
      in regard to the ischemia-reperfusion injury induced on the microsurgical breast free flap
      during transfer to receiving area. The investigators will evaluate the continuous flap tissue
      oximetry and the level of biochemical markers.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2013</start_date>
  <completion_date type="Actual">February 2015</completion_date>
  <primary_completion_date type="Actual">September 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>continuous tissue oximetry (NIRS)</measure>
    <time_frame>20 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Biochemical Markers</measure>
    <time_frame>Preoperative and 24 hours post operative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lactate Clearance</measure>
    <time_frame>24 hours</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">132</enrollment>
  <condition>Microsurgical Free Flaps</condition>
  <arm_group>
    <arm_group_label>Total intravenous anesthesia</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Total intravenous anaesthesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Balanced anesthesia</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Balanced anesthesia</intervention_name>
    <description>Et-Sevo maIntained 1,8-2%, remifentanyl according target-controlled infusion maintained 1-3 ng/ml</description>
    <arm_group_label>Balanced anesthesia</arm_group_label>
    <other_name>Inhalation anesthesia</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Total intravenous anesthesia</intervention_name>
    <description>Propofol 3-4 Âµg/ml and remifentanyl 1-3 ng/ml according target-controlled infusion</description>
    <arm_group_label>Total intravenous anesthesia</arm_group_label>
    <other_name>TIVA-TCI</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Patient selected for plastic breast surgery With microsurgical Free flap Over 18 y Asa I/II

        Exclusion Criteria:

        Unusual reaction to anesthetic drugs Suspect for malignant hyperthermia Vasculopathic
        disease Coagulation disease
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ester Forastiere, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Regina Elena CI</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Regina Elena CI</name>
      <address>
        <city>Rome</city>
        <zip>00144</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>April 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 18, 2013</study_first_submitted>
  <study_first_submitted_qc>July 22, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 23, 2013</study_first_posted>
  <last_update_submitted>April 6, 2016</last_update_submitted>
  <last_update_submitted_qc>April 6, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 7, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Regina Elena Cancer Institute</investigator_affiliation>
    <investigator_full_name>Ester Forastiere</investigator_full_name>
    <investigator_title>M.D., Chief of Critical Area Department</investigator_title>
  </responsible_party>
  <keyword>Balanced anesthesia</keyword>
  <keyword>Inhalation anesthesia</keyword>
  <keyword>Reperfusion injury</keyword>
  <keyword>Microsurgical Free flap</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Reperfusion Injury</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Sevoflurane</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

